Schedule 13G ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2018-01-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-045654
- Form type
- SC 13G
- Filer
- NOVARTIS AG
- CIK
- CIK 1114448
- Filed
- Feb 14, 2018
- Reporting period
- Jan 30, 2018
- Description
- Schedule 13G beneficial ownership